Print Email Facebook Twitter Quantitation of ortho-cresyl phosphate adducts to butyrylcholinesterase in human serum by immunomagnetic-UHPLC-MS/MS Title Quantitation of ortho-cresyl phosphate adducts to butyrylcholinesterase in human serum by immunomagnetic-UHPLC-MS/MS Author Johnson, D. Carter, M.D. Crow, B.S. Isenberg, S.L. Graham, L.A. Erol, H.A. Watson, C.M. Pantazides, B.G. van der Schans, M.J. Langenberg, J.P. Noort, D. Blake, T.A. Thomas, J.D. Johnson, R.C. Publication year 2015 Abstract Tri-ortho-cresyl phosphate (ToCP) is an anti-wear, flame retardant additive used in industrial lubricants, hydraulic fluids and gasoline. The neurotoxic effects of ToCP arise from the liver-activated metabolite 2-(o-cresyl)-4H-1,3,2-benzodioxaphosphoran-2-one (cresyl saligenin phosphate or CBDP), which inhibits esterase enzymes including butyrylcholinesterase (BChE). Following BChE adduction, CBDP undergoes hydrolysis to form the aged adduct ortho-cresyl phosphoserine (oCP-BChE), thus providing a biomarker of CBDP exposure. Previous studies have identified ToCP in aircraft cabin and cockpit air, but assessing human exposure has been hampered by the lack of a laboratory assay to confirm exposure. This work presents the development of an immunomagnetic-UHPLC-MS/MS method for the quantitation of unadducted BChE and the long-term CBDP biomarker, oCP-BChE, in human serum. The method has a reportable range from 2.0ng/ml to 150ng/ml, which is consistent with the sensitivity of methods used to detect organophosphorus nerve agent protein adducts. The assay demonstrated high intraday and interday accuracy (≥85%) and precision (RSD≤15%) across the calibration range. The method was developed for future analyses of potential human exposure to CBDP. Analysis of human serum inhibited in vitro with CBDP demonstrated that the oCP-BChE adduct was stable for at least 72h at 4, 22 and 37 C. Compared to a previously reported assay, this method requires 75% less sample volume, reduces analysis time by a factor of 20 and demonstrates a threefold improvement in sensitivity. Published 2015. This article is a U.S. Government work and is in the public domain in the USA. © Published 2015. This article is a U.S. Government work and is in the public domain in the USA. Subject Observation, Weapon & Protection SystemsCBRN - CBRN ProtectionTS - Technical SciencesButyrylcholinesteraseDresyl saligenin phosphateJamaica ginger paralysisOrganophosphate-induced delayed neuropathyTri-ortho-cresyl-phosphateBody fluidsCabins (aircraft)CalibrationEnzymesLubricantsTribologyButyrylcholinesteraseEsterase enzymesFlame-retardant additivesHuman exposuresIndustrial lubricantsJamaicaNeurotoxic effectsOrganophosphate-induced delayed neuropathyCockpits (aircraft)CholinesteraseTri ortho cresyl phosphateAccuracyCholinesterase blood levelControlled studyIn vitro studyLimit of detectionTandem mass spectrometryUltra performance liquid chromatographyZingiber officinale To reference this document use: http://resolver.tudelft.nl/uuid:fd3c6c2a-1ae0-423a-83c6-d95a18622334 DOI https://doi.org/10.1002/jms.3576 TNO identifier 527060 Publisher John Wiley and Sons Ltd ISSN 1076-5174 Source Journal of Mass Spectrometry, 50 (4), 683-692 Document type article Files To receive the publication files, please send an e-mail request to TNO Library.